Aronora Email Format
Biotechnology ResearchOregon, United States11-50 Employees
Aronora is a clinical-stage biotechnology company focused on developing therapies for cardio-hematologic diseases with significant unmet medical need. Based in Portland, Oregon, the organization concentrates on advancing treatments for blood clotting disorders, aiming to address gaps in current care. As a smaller firm in the biotech research space, it seeks to translate scientific findings into clinical candidates. The work sits at the crossroads of cardiovascular and hematologic disciplines, with the goal of expanding options for patients worldwide. Aronora has engaged in external collaborations to support its development programs, including a 2023 partnership with Samsung BioLogics to help advance its next-generation therapeutics for blood clotting diseases. Earlier, in 2019, the company entered an agreement with XOMA related to royalty rights on five drug candidates.